HIV and AIDS Trial, Recruiting NCT07089836 Sponsor: American Laboratory Products Company Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT07089836
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any gender are eligible to participate.
  • People who are currently being tested for syphilis for any reason — such as being at risk without symptoms, having symptoms, having had syphilis before, or being considered high risk — or people who have already been diagnosed with syphilis through a test done at an accredited laboratory.
  • People who are willing to provide the required blood samples for the study, in addition to any samples their own doctor requests.
  • Pregnant people and children under 22 years old would need to provide one tube of blood for the study.
  • All other participants (excluding pregnant people and those under 22) would need to provide two tubes of blood for the study.
  • People who are able and willing to sign a consent form agreeing to take part.
  • Young people aged 13 to 17 would be asked to sign their own agreement form written in age-appropriate language, and a parent or guardian would also need to give written consent before the young person could be enrolled.

Who may not be able to join:

  • People who are currently taking antibiotics, or who have finished a course of antibiotics within the last 30 days.
  • People with existing health conditions that could make having blood drawn difficult or potentially harmful.
  • Cases where blood samples cannot be collected following the study's strict collection process, as assessed by the study team.
  • People whose medical, psychological, or social circumstances — in the opinion of the study investigator — could affect their ability to follow study requirements, put their safety at risk, or affect the reliability of the study results.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 800-592-5726

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
American Laboratory Products Company
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Positive and Negative Percent Agreement of the ALPCO Syphilis-T and Syphilis-NT CLIA Kits

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov